In summary, we demonstrate a significant association between CHIP and incident CVD after HCT in patients with MM, with the strongest association noted among patients undergoing HCT with modifiable risk factors, such as hypertension and diabetes. The gene discussed is STUB1; the disease is Miyoshi myopathy.